Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-060779
Filing Date
2026-05-26
Accepted
2026-05-26 08:00:20
Documents
2
Period of Report
2026-05-26

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0292123-6k_kazia.htm 6-K 10120
2 PRESS RELEASE DATED MAY 26, 2026 ea029212301ex99-1.htm EX-99.1 12796
  Complete submission text file 0001213900-26-060779.txt   24222
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 261015973
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)